Reactivation of hepatitis B virus infection after cytotoxic chemotherapy or immunosuppressive therapy

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 17, Issue 12

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

503

HTML

4104

Tables (1-3)

Sum=4635

Mar 28, 2011 (publication date) through Apr 24, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Topic Highlight

World J Gastroenterol. Mar 28, 2011; 17(12): 1531-1537
Published online Mar 28, 2011. doi: 10.3748/wjg.v17.i12.1531

Table 1 Onco-hematological diseases and reactivation of hepatitis B

Hematologic diseases	Hematological tumors
Non-hodgkin lymphoma	Breast cancer
Hodgkin lymphoma	Lung cancer
Chronic lymphocytic leukemia	Hepatocellular carcinoma
Chronic myeloid leukemia	Nasopharyngeal cancer
Acute myeloid leukemia	Other cancers
Acute lymphoblastic leukemia
Multiple myeloma
Waldenstrom macroglobulinemia
Plasmacytoma
Aplastic anemia
Myelodysplastic syndrome
Bone marrow transplantation

Citation: Manzano-Alonso ML, Castellano-Tortajada G. Reactivation of hepatitis B virus infection after cytotoxic chemotherapy or immunosuppressive therapy. World J Gastroenterol 2011; 17(12): 1531-1537
URL: https://www.wjgnet.com/1007-9327/full/v17/i12/1531.htm
DOI: https://dx.doi.org/10.3748/wjg.v17.i12.1531